Member Info for Timster

Seems like those who want to be in are well and truly planted and not too many interested

more lateral flow test.... interesting...

I suspect Global got his fantasy trade in anyway...

yanks are up early ;)

BAMS will give Affimers the spotlight though (or if they are first LFD, waste water)

exciting month to come so much news

got to be a bit of FOMO later too shirley

I'm also thinking first second week of September for validation purely based on how long other tests have taken, the LFD has been in for 3 weeks today.
BUT would have thought BAMS would be closer

CLINICAL VALIDATION IS 100% OUT OF AVACTAS HANDS!!!!!!!

how many more ****in times has it got to be said ffs

Don't do pointless antibody tests round these parts this is the awacta board for Awacta people

Wrong board

when has he been right?

Too early for Lateral flow I think but BAMS a possibility...

3 weeks tomorrow big Al said this:

Dr. Alastair Smith, Chief Executive of Avacta Group commented:

"I am delighted to have established this collaboration with the Liverpool School of Tropical Medicine. It is an important partnership which provides Avacta with access to patient samples both in the UK and abroad, where the incidence of the disease is currently much higher, to ensure prompt access to a sufficient number of samples for clinical validation.

We have been working with the Liverpool School of Tropical Medicine for some time to define the target performance specifications of the saliva-based rapid test and their insight has been tremendously helpful in this regard.

From the timescales we have seen for other validation then its possible we get a result next week. Is it quicker to assess a lateral flow device though, anyone know?

was going to suggest investing dot com, I think that and google go off the last trade so they are fairly accurate price wise

does appear to be a test that you cant administer at home (currently) so it has its place but not the same market as Avacta:

The current method for testing for Covid-19 involves a swab test, after which, people have to self-isolate for up to 72 hours whilst they wait to receive their results.

If the trial is successful, it could cut the wait down to just 10 minutes and allow people to return to normal life almost immediately if they get a negative result.

If the test is proven to be effective, the new test could be rolled out quickly to testing centres, due to how simple it is to train people on how to perform the test.

sounds good:
The new test, developed by ANCON Medical, would require the patient to breathe into a mouthpiece for one minute so that a sample of the chemicals in their breath can be collected.

These chemicals are then analysed by a supercomputer and compared to those found in the breath of infected patients.

is the super computer mandatory?

@cristalball how can you say the company is opaque??
13th july --- collaboration with Integumen
22nd July --- update on Adeptrix COVID-19 Diagnostic test
29th July --- Expanded partnership with Daewoong
6th Aug ---- COVID-19 rapid test manufacturing partner
7th Aug ---- COVID-19 test collaboration
11th Aug ---- Therapeutics chief development officer announced
17th Aug ---- Calrify Medusa are muppets
18th Aug ---- Expanded partnership with LG chem life sciences

we've not had an RNS in 7 trading days and they are opaque?

great post! spot on!

global just made 47p

surprised no ones mentioned ncyt announcing a respiratory test that differentiates flu from covid-19.

@PL75 you need to get your lawyers on this pronto!

I think we will be getting our bumper new next week though and I certainly wouldn't risk being out over the long weekend

Excellent post, as has been said hard to get away with the lies on this board because of the very knowledgeable posters.
Can we just all agree to ignore and filter the twat tomorrow